Studies across gastrointestinal, musculoskeletal, neurological, vascular, and inflammatory models consistently show BPC-157 acts as a pleiotropic compound
GLP-1 Glucagon-like peptide-1
Low dose: Mild inflammation, early arthritis, preventive use Mid dose: Moderate joint pain, post-surgical recovery, chronic conditions High dose: Severe injuries, advanced arthritis vet-supervised only How BPC-157 Is Given to Dogs There are two main routes: injection and oral
Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications
Visit pspeptides.com/shop, browse research-grade peptides verified at 99%+ purity, and add your selections to the cart
Balanced Perspective : BPC-157 remains investigational rather than proven therapy, so safety and effectiveness require stronger human clinical evidence before routine medical use